Allena Pharmaceuticals Inc EV/EBIT
Qual é o EV/EBIT de Allena Pharmaceuticals Inc?
O EV/EBIT de Allena Pharmaceuticals Inc é N/A
Qual é a definição de EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT de empresas na Setor Health Care em NASDAQ em comparação com Allena Pharmaceuticals Inc
Empresas com ev/ebit semelhantes a Allena Pharmaceuticals Inc
- Hi Crush Inc tem EV/EBIT de N/A
- Cocrystal Pharma Inc tem EV/EBIT de N/A
- Panorama Capital tem EV/EBIT de N/A
- Nuverra Environmental Solutions Inc tem EV/EBIT de N/A
- Touchpoint tem EV/EBIT de N/A
- Equity Metals tem EV/EBIT de N/A
- Allena Pharmaceuticals Inc tem EV/EBIT de N/A
- Queen's Road Capital Investment tem EV/EBIT de N/A
- Uxin Ltd tem EV/EBIT de N/A
- Red Light Holland tem EV/EBIT de N/A
- St. James Gold tem EV/EBIT de N/A
- Eat Beyond Global tem EV/EBIT de N/A
- Consolidated Firstfund Capital tem EV/EBIT de N/A